<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-98133</identifier>
<setSpec>1576-9895</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Pulmonary Aspergilloma with good response to an antifungal agent</dc:title>
<dc:description xml:lang="en">Abstract. Aspergillus sp is a ubiquitous family of fungi that are acquired through the inhalation of spores. Aspergilloma is the most common and best known of pulmonary involvement by Aspergillus. It is characterized by a ball made up of fungal hyphae, inflammatory cells, fibrin, mucus and debris holders. Typically, the Aspergilloma is forming in a pre-existing   avity in the lung, caused by various diseases such as tuberculosis, sarcoidosis, bronchiectasis, cystic fibrosis, bullae, ankylosing spondylitis, tumors or lung infections. Clinically, patients are often asymptomatic being the hemoptisis the most common symptom. The diagnosis of the disease is based on clinical findings and in the radiography, combined with serology and microbiologic cultures. The treatment is controversial depending on several factors. We present two cases of Aspergilloma who have been treated with Itraconazole with good results (AU)</dc:description>
<dc:creator>Romero de Tejada, J. G</dc:creator>
<dc:creator>Cano, P</dc:creator>
<dc:creator>Martín, C</dc:creator>
<dc:creator>Girón, R. M</dc:creator>
<dc:creator>Segrelles, G</dc:creator>
<dc:creator>Gómez Púnter, R. M</dc:creator>
<dc:creator>Pinedo, C</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Resumen. Aspergillus sp es una familia de hongos ubicuos que se adquieren mediante la inhalación de esporas y, en pacientes predispuestos, produce afectación pulmonar, siendo el aspergiloma la forma más común y mejor conocida. Se caracteriza por una bola fúngica constituida por hifas del hongo, células inflamatorias, fibrina, moco y restos titulares. Habitualmente, el aspergiloma se forma en una cavidad pre-existente del pulmón causada por diferentes patologías como  tuberculosis, sarcoidosis, bronquiectasias, fibrosis quística, bullas, espondilitis anquilosante, neoplasias o infecciones pulmonares. Clínicamente los pacientes suelen estar asintomáticos o paucisintomáticos siendo la hemoptisis el síntoma más frecuente. El diagnóstico de la enfermedad se basa en la clínica y en los hallazgos de la radiografía, combinado con la serología y los cultivos microbiológicos. El tratamiento del aspergiloma es controvertido, dependiendo de varios factores. Presentamos dos casos de aspergiloma que han sido tratados con itraconazol con buena evolución (AU)</dc:description>
<dc:source>Rev. patol. respir;12(3): 124-127, jul.-sept. 2009. ilus</dc:source>
<dc:identifier>ibc-98133</dc:identifier>
<dc:title xml:lang="es">Aspergiloma pulmonar con buena respuesta a antifúngico</dc:title>
<dc:subject>^d8352^s22046</dc:subject>
<dc:subject>^d53080^s22057</dc:subject>
<dc:subject>^d8349^s22016</dc:subject>
<dc:subject>^d31378^s22073</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d943^s22073</dc:subject>
<dc:subject>^d1237^s22052</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d19059</dc:subject>
<dc:subject>^d20174</dc:subject>
<dc:type>article</dc:type>
<dc:date>200909</dc:date>
</metadata>
</record>
</ibecs-document>
